Results 131 to 140 of about 89,659 (294)

Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18‐month follow‐up of a randomized clinical trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims In a six‐month randomized clinical trial, improved peripheral perfusion has been shown with liraglutide, associated with favourable vascular effects in people with type 2 diabetes and peripheral artery disease (PAD). We aimed to evaluate the durability of these benefits and to elucidate some mechanisms underlying liraglutide's effect over
Paola Caruso, Maria Ida Maiorino, Miriam Longo, Antonietta Maio, Lorenzo Scappaticcio, Nicole Di Martino, Carla Carbone, Mariluce Barrasso, Mariangela Caputo, Maurizio Gicchino, Giuseppe Bellastella, Dario Giugliano, Katherine Esposito   +12 more
wiley   +1 more source

Specific inhibition of ADP‐induced platelet aggregation by clopidogrel in vitro [PDF]

, 1999
Artur‐Aron Weber, Stephanie Reimann, Karsten Schrör   +2 more
openalex   +1 more source

Data augmentation method for modeling health records with applications to clopidogrel treatment failure detection [PDF]

arXiv
We present a novel data augmentation method to address the challenge of data scarcity in modeling longitudinal patterns in Electronic Health Records (EHR) of patients using natural language processing (NLP) algorithms. The proposed method generates augmented data by rearranging the orders of medical records within a visit where the order of elements ...
arxiv  

Number of Major Vascular Events Prevented by Clopidogrel versus other Cardiovascular Therapies [PDF]

, 1998
José Biller
openalex   +1 more source

Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction

Circulation, 2004
Background— Although clopidogrel reduces the risk of cardiovascular episodes after coronary events and stenting, a substantial number of incidents continue to occur. Methods and Results— The antiplatelet effect of clopidogrel was studied prospectively in
S. Matetzky, B. Shenkman, V. Guetta, M. Shechter, R. Beinart, I. Goldenberg, I. Novikov, H. Pres, N. Savion, D. Varon, H. Hod   +10 more
semanticscholar   +1 more source

Right ventricular strain and tricuspid annular plane systolic excursion are associated with mortality in inferior ST‐elevation myocardial infarction

European Journal of Clinical Investigation, EarlyView.
The right ventricular longitudinal strain, right ventricular free wall strain and the tricuspid annular plane systolic excursion are associated with all‐cause mortality in patients with acute inferior ST‐segment elevation myocardial infarction.
Michael Poledniczek, Andreas Kammerlander, Caroline Jansen, Daniel Feser, Severin Ehrengruber, Eva Steinacher, Christian Hengstenberg, Alexander Niessner, Irene Lang, Thomas Binder, Bernhard Richter   +10 more
wiley   +1 more source

Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel [PDF]

, 2000
Charles L. Bennett, Jean M. Connors, John Carwile, Joel L. Moake, William R. Bell, Stefano Tarantolo, Leo J. McCarthy, Ravi Sarode, Amy J. Hatfield, Marc D. Feldman, Charles J. Davidson, Han‐Mou Tsai   +11 more
openalex   +1 more source

Mandibular third molar coronectomy in older adults and its effects on oral health‐related quality of life

Gerodontology, EarlyView.
Objective The purpose of this study was to investigate the effect of coronectomy on postoperative quality of life in older adults. Background Coronectomy is an alternative to complete surgical removal of a mandibular third molar that lies close to the inferior alveolar nerve.
Rashida N. Simons, Jerome A. Lindeboom, Jacco G. Tuk, Jan de Lange   +3 more
wiley   +1 more source

Is clopidogrel superior to aspirin in secondary prevention of vascular disease? [PDF]

, 2000
Ale Algra, J. van Gijn
openalex   +1 more source

Recombinant Activated Factor VIIa Combined With Tranexamic Acid Control Haemostasis in Patients With Severe Factor XI Deficiency Undergoing Urological Procedures

Haemophilia, EarlyView.
ABSTRACT Introduction Patients with severe Factor XI deficiency face unique challenges during urological procedures due to an elevated risk of bleeding, balanced against the use of tranexamic acid (TXA), which may form blood clots. Given the limitations associated with plasma‐based treatment, there have been reports of successful and safe off‐label use
Neta Sternbach, Yaron Ehrlich, Anfisa Stenevsky, Daniel Saidian, Darawsha Abd Elhalim, Jack Baniel, Pia Raanani, Galia Spectre   +7 more
wiley   +1 more source